| 证券代码：603585 | 证券简称：苏利股份 | 公告编号：2026-010 | | --- | --- | --- | | 转债代码：113640 | 转债简称：苏利转债 | | 江苏苏利精细化工股份有限公司 可转债转股结果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 累计转股情况："苏利转债"的转股起止日期为 2022 年 8 月 22 日至 2028 年 2 月 15 日。截至 2026 年 3 月 31 日，累计共有 47,121,000 元"苏利转债"转 换为江苏苏利精细化工股份有限公司（以下简称"公司"）A 股股票，累计转股 数量为 2,739,052 股，占可转债转股前公司已发行股份总额的 1.5217%。 未转股可转债情况：截至 2026 年 3 月 31 日，尚未转股的可转债金额为 910,081,000 元，占"苏利转债"发行总额的 95.0763%。 本季度转股情况：2026 年第一季度共有 400 张"苏利转债"转换为公司 股票，转股数为 2,325 股。 ...

| 证券代码：603585 | 证券简称：苏利股份 | 公告编号：2026-009 | | --- | --- | --- | | 转债代码：113640 | 转债简称：苏利转债 | | 江苏苏利精细化工股份有限公司 经公司自查并向控股股东及实际控制人核实，公司经营情况正常，不存 在应披露而未披露的重大事项。 公司近日股价波动幅度较大，敬请广大投资者理性决策，审慎投资。 一、股票交易异常波动的具体情况 本公司股票连续三个交易日（2026 年 3 月 26 日、27 日、30 日）内收盘价 格涨幅偏离值累计达 20%以上，属于《上海证券交易所交易规则》规定的股票交 易异常波动情形。 二、公司关注并核实的相关情况 （一）公司生产经营情况 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 江苏苏利精细化工股份有限公司（以下简称"公司"）股票于 2026 年 3 月 26 日、3 月 27 日、3 月 30 日连续三个交易日内收盘价格涨幅偏离值累计超过 20%，根据《上海证券交易所交易规则》的 ...

特此回函。 2026年3月30日 江苏苏利精细化工股份有限公司: 你公司发来的《江苏苏利精细化工股份有限公司股票交易异常波动问询函》 已收悉。经本人自查确认,现将相关事项回复如下: 本人作为江苏苏利精细化工股份有限公司的控股股东及实际控制人,截至目 前,不存在影响你公司股票交易异常波动的重大事项;不存在其他应披露而未披 露的重大信息,包括但不限于重大资产重组、股份发行、重大交易类事项、业务 重组、股份回购、股权激励、破产重整、重大业务合作、引进战略投资者等重大 事项;不存在可能导致公司股权发生变化的事项;股票交易异常波动期间,本人 未买卖你公司股票。 江苏苏利精细化工股份有限公司 股票交易异常波动问询函的回函 ...

Market Overview - On March 27, the stock indices in both markets surged, with the Shanghai Composite Index returning above 3900 points, and the ChiNext Index and others rising over 1% [1][2] - The total trading volume in the Shanghai and Shenzhen markets was approximately 1.86 trillion yuan, a decrease of about 93 billion yuan compared to the previous day [2] Pharmaceutical Sector - The pharmaceutical sector showed strong performance, particularly in innovative drugs and weight-loss drug concepts, with companies like Shuyou Shen and Rejing Bio hitting the daily limit [2][5] - Key stocks included: - Shuyou Shen: +20.02% [6] - Rejing Bio: +20.00% [6] - Baili Tianheng: +12.46% [6] - The overall trend for innovative drugs is upward, supported by improved funding conditions and competitive advantages of domestic innovative drugs [8] Lithium Battery Sector - The lithium battery sector experienced a significant surge, with Haike New Energy hitting the daily limit and reaching a historical high [10] - Notable stock performances included: - Haike New Energy: +20.00% [11] - Rongjie Co.: +20.00% [11] - Ganfeng Lithium: +10.00% [11] - Demand for lithium batteries is expected to explode due to high oil prices, with global orders for lithium batteries increasingly directed towards China [12] Chemical Sector - The chemical sector was active, with stocks like Dinglong Co. and Shandong Haohua hitting the daily limit [14] - Key stock performances included: - Dinglong Co.: +17.33% [15] - Six Nations Chemical: +10.07% [15] - The rise in methanol prices has been noted, with a significant increase of 72% since the outbreak of the Middle East conflict [16] - Bromine prices also surged, with a 52.78% increase compared to the beginning of the month [17] - The chemical industry is currently experiencing a large-scale destocking cycle, with expectations for a recovery in profitability as demand rebounds post-conflict [17]

Market Overview - The A-share market opened lower but closed higher, with the Shenzhen Component Index rising over 1% [1] - The total trading volume in the Shanghai and Shenzhen markets was 1.85 trillion, a decrease of 903 billion compared to the previous trading day [1][5] - More than 4,300 stocks in the market experienced gains, indicating a broad-based rally [1] Sector Performance - The lithium battery industry chain saw significant gains, with multiple stocks hitting the daily limit, including Rongjie Co., Ltd. with four consecutive limit-ups and Shida Shenghua with two consecutive limit-ups [1] - The pharmaceutical sector also performed well, with Keta Bio hitting the daily limit and several other stocks showing strong upward momentum [1] - The chemical sector was active, with stocks like Suli Co., Ltd. and Luban Chemical hitting the daily limit [1] Declines - In contrast, several stocks in the green energy sector experienced declines, with Liaoning Energy hitting the limit down and other companies like Jieneng Wind Power and Hunan Development also facing significant drops [2] Closing Statistics - At the close, the Shanghai Composite Index rose by 0.63%, the Shenzhen Component Index increased by 1.13%, and the ChiNext Index gained 0.71% [3][4]

Market Overview - The A-share market opened lower but rebounded, with all three major indices turning positive. The half-day trading volume in the Shanghai and Shenzhen markets was 1.14 trillion, a decrease of 84.3 billion compared to the previous trading day [1]. Stock Performance - Over 3,700 stocks in the market rose, indicating a broad-based rally [2]. Sector Highlights - The lithium mining sector saw significant gains, with Rongjie Co. achieving a four-day consecutive rise, while Jiangte Electric, Jinyuan Co., and Shengxin Lithium Energy hit the daily limit [3]. - The pharmaceutical sector also performed strongly, with Keta Bio reaching the daily limit, Meinuohua achieving five gains in six days, and Wanbangde recording three gains in four days. Lianhuan Pharmaceutical and Shuanglu Pharmaceutical also hit the daily limit [3]. - The chemical sector was active, with Sully Co., Lubai Chemical, and Jinzheng all reaching the daily limit [3]. Declines - In contrast, several stocks in the green energy sector experienced declines, with Liaoning Energy hitting the daily limit down, and both Jieneng Wind Power and Haili Wind Power seeing significant drops [4]. Closing Summary - By the end of the trading session, the Shanghai Composite Index rose by 0.26%, the Shenzhen Component Index increased by 0.93%, and the ChiNext Index was up by 0.83% [5].

重要内容提示： 已履行的审议程序：江苏苏利精细化工股份有限公司（以下简称"公 司"）于 2025 年 4 月 22 日召开第五届董事会第四次会议及第五届监事会第二 次会议，审议通过了《关于使用部分闲置募集资金及自有资金进行现金管理 的议案》，同意公司使用额度不超过 3.00 亿元的闲置募集资金购买安全性高、 流动性好、有保本约定的理财产品或存款类产品，投资产品的期限不超过 12 个月。公司董事会、监事会及保荐机构已分别对此发表了同意的意见。具体 内容详见公司于 2025 年 4 月 24 日在指定信息披露媒体上披露的《江苏苏利 精细化工股份有限公司关于使用部分闲置募集资金及自有资金进行现金管理 的公告》（公告编号：2025-038）。 特别风险提示：本次购买的理财产品安全性高、流动性好、有保本约 定，属于低风险投资产品，但金融市场受宏观经济、财政及货币政策的影响 较大，不排除该项投资可能受到市场波动的影响。 委托理财种类：结构性存款 委托理财金额：人民币 3,000 万元 一、本次委托理财概述 | 证券代码：603585 | 证券简称：苏利股份 | 公告编号：2026-008 | | --- | --- | ...

Group 1: Company Performance - The company, Sulih Co., Ltd. (603585), expects a net profit attributable to shareholders for the year 2025 to be between 190 million and 220 million yuan, marking a turnaround from losses in the previous year, primarily due to the recovery in global agrochemical market demand and capacity release [1] Group 2: Stock Performance - On February 2, 2026, Sulih's stock price fell by 5%, closing at 20.51 yuan per share; on February 6, 2026, the stock closed at 20.25 yuan per share, with a turnover rate of 2.13%, indicating short-term market volatility [2] Group 3: Subsidiary Development - On December 25, 2025, the company announced plans to increase capital in its subsidiary, Sulih (Ningxia) New Materials Technology Co., Ltd., contributing 76.6333 million yuan to accelerate the construction of the Ningxia new materials project, while maintaining a 76% ownership stake [3]

| 证券代码：603585 | 证券简称：苏利股份 | 公告编号：2026-007 | | --- | --- | --- | | 转债代码：113640 | 转债简称：苏利转债 | | 江苏苏利精细化工股份有限公司 关于使用部分闲置募集资金进行现金管理的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 已履行的审议程序：江苏苏利精细化工股份有限公司（以下简称"公 司"）于 2025 年 4 月 22 日召开第五届董事会第四次会议及第五届监事会第二 次会议，审议通过了《关于使用部分闲置募集资金及自有资金进行现金管理 的议案》，同意公司使用额度不超过 3.00 亿元的闲置募集资金购买安全性高、 流动性好、有保本约定的理财产品或存款类产品，投资产品的期限不超过 12 个月。公司董事会、监事会及保荐机构已分别对此发表了同意的意见。具体 内容详见公司于 2025 年 4 月 24 日在指定信息披露媒体上披露的《江苏苏利 精细化工股份有限公司关于使用部分闲置募集资金及自有资金进行现金管理 的公告》（公告编号：20 ...

Core Viewpoint - Jiangsu Suli Fine Chemical Co., Ltd. will begin paying interest on its convertible bonds on February 24, 2026, for the period from February 16, 2025, to February 15, 2026, as per the terms outlined in the bond prospectus [2][15]. Group 1: Bond Details - The convertible bonds were issued on February 16, 2022, with a total issuance amount of RMB 957.211 million [5]. - The bond has a term of 6 years, maturing on February 16, 2028 [2]. - The interest rates for the bond are structured as follows: 0.4% for the first year, 0.6% for the second year, 1% for the third year, 1.5% for the fourth year, 2% for the fifth year, and 3% for the sixth year [2]. Group 2: Interest Payment Information - The interest payment for the fourth year will be at a rate of 1.5%, resulting in a payment of RMB 1.50 per bond (before tax) [15][18]. - The bondholder registration date for interest payment is February 13, 2026, with the interest payment date also set for February 24, 2026 [4][16]. - The interest income will be subject to a 20% personal income tax for individual investors, resulting in a net payment of RMB 1.20 per bond after tax [18]. Group 3: Conversion and Pricing - The initial conversion price for the bonds was set at RMB 20.11 per share, which has been adjusted to RMB 19.16 per share due to profit distribution [10]. - The conversion period for the bonds began on August 22, 2022, and the bonds can be converted into company shares [9]. - The bond's credit rating is "AA-" with a stable outlook, as assessed by Shanghai New Century Credit Rating Co., Ltd. [12][13].